Advisory Board

Cristián Moreno Terrazas, MBA

Cristián Moreno Terrazas, MBA is CEO of Innovation and Entrepreneurship for the Chilean Industries Federation — SOFOFA.
Cristián has 18 years experience in developing new business and investment, fostering innovation and entrepreneurship and promoting new public policy and government programs. He has worked and lived in Dublin, Tokyo, Rotterdam, Philadelphia, and several cities in Latin America.
Cristián earned an MBA in International Business from the Universidad Gabriela Mistral (Chile), a BS in Agribusiness Management, and a Bachelor of Science in Business Administration from the Universidad Central de Chile. He has been awarded Ministry of Foreign Affairs scholarships.
In the private sector, he has served as Chief Investment Officer for CIFCO Holding, linked to the Ergas family, pushing a technology investment fund with a portfolio in Palo Alto, Santiago, Buenos Aires, and Sao Paulo; an ambitious real estate and innovative hotel chain along Chile/Latin America; and the launch of an air logistics (helicopter) services company and has been involved in several processes of private equity.
Cristián has also represented Unifrutti Traders (Mediterranean fresh fruit and Chile’s largest export company) in the European market and expanded the first “cultural” shopping mall in Santiago (PatioBellavista).
In the public sector, he served as “Chile” Brand Officer for the Asia Pacific Region, and cofounded the Inward investment promotion engine of the Chilean Government, introducing new high tech companies to the Chilean economy and promoting new entrepreneurs. Currently, as CEO Innovation and Entrepreneurship for the Chilean Industries Federation — SOFOFA — he is pushing to introduce exponential technologies awareness and creating cultural change for innovation at different levels (Country, Corporation, Government, Business Association, and Educational Institutions).
On behalf of the private sector, Cristián is board member of the Chilean Science and Technology Fund (FONDEF_CONICYT).